跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 27,848 条关于
“atypical teratoid/rhabdoid tumors”
全部
27,848
临床试验
21,632
药物
520
机构
55
资讯
5,641
去年
LP-184 Receives FDA Rare Pediatric Disease Designations for Three Cancer Types
去年
Paxalisib's Glioblastoma Pathway: FDA Suggests Standard Approval, Phase 3 Trial Alignment
去年
Lantern Pharma's LP-184 Demonstrates Significant Survival Benefits in Pediatric Brain Cancer Models
3个月前
Kazia Therapeutics Triples Enrollment in Phase 1b Trial of Paxalisib for Advanced Triple Negative Breast Cancer
9个月前
PEDMARK Shows Significant Reduction in Cisplatin-Induced Hearing Loss in Japanese Pediatric Cancer Study
去年
FDA to Discuss Paxalisib Registration Pathways for Glioblastoma with Kazia Therapeutics
去年
Lantern Pharma Reports Complete Responses in Two Cancer Trials, Advances AI-Driven Pipeline
7个月前
Aminex Therapeutics Initiates Phase 1b/2 Trial of Novel Polyamine-Targeting Cancer Therapy AMXT 1501 Plus DFMO
上个月
Lantern Pharma Secures USPTO Notice of Allowance for Biomarker-Guided Patent on LP-184 in Multiple Solid Tumors
去年
Lantern Pharma Receives FDA Guidance for Pediatric CNS Cancer Trial Targeting ATRT
第 1 页，共 565 页
上一页
下一页
